Tecta side effects and health risks associated with PPIs

Proton pump inhibitors (PPIs) such as Tecta (pantoprazole), Losec (omeprazole) and Nexium (esomeprazole) are among the most widely used medications in Canada. They treat heartburn, gastroesophageal reflux disease (GERD), esophagitis and stomach ulcers, and are part of the treatment for Helicobacter pylori infection. For most people they are safe and effective, but like all medications they can cause side effects, and many people take them for years. Your genes, especially CYP2C19, affect how much of the drug stays in your body and may influence both how well a PPI works and your risk of side effects.

What are the common side effects of Tecta?

Short-term side effects are usually mild and include headache, nausea, diarrhea, constipation, stomach pain and gas. They often improve with time. Contact your health care provider if side effects are severe or do not go away.

What are the long-term risks of PPIs?

Many observational studies have linked long-term PPI use to problems such as bone fractures, pneumonia, kidney disease and dementia. However, these studies cannot prove that PPIs caused the problems, because people who take PPIs long term are often older and have more health conditions.

What about dementia? A 2026 review that combined 23 studies of older adults found that people who took PPIs were slightly more likely to develop dementia, about 18% more likely. However, people who took other heartburn medications called H2 blockers, such as famotidine (Pepcid), had about the same risk.

The strongest evidence comes from the COMPASS trial, led from McMaster University, in which 17,598 people took pantoprazole (Tecta) or a placebo for about 3 years. Pantoprazole did not increase the risk of pneumonia, fractures, kidney disease, dementia, cancer or death. The only difference was a small increase in gut infections (1.4% compared with 1.0%).

Some effects of long-term use are well established, because less stomach acid can affect how the body absorbs nutrients and fights germs:

• Low magnesium, which can cause muscle cramps, weakness or an irregular heartbeat.
• Low vitamin B12, especially in older adults who take a PPI for years.
• Gut infections, including C. difficile, a cause of severe diarrhea.
• Rebound acid when stopping. In a randomized trial, 44% of healthy people developed acid symptoms after stopping an 8-week PPI course, compared with 15% on placebo. This is why PPIs are often tapered rather than stopped suddenly.

How do genes affect PPI side effects?

Most PPIs, including Tecta, are broken down by the CYP2C19 enzyme in the liver. How fast it works depends on your CYP2C19 genes:

• Poor and intermediate metabolizers clear PPIs slowly, so they have higher drug levels. About 2 in 100 people of European ancestry and about 13 in 100 people of East Asian ancestry are poor metabolizers. The CPIC guideline suggests considering a 50% lower dose for long-term treatment once symptoms are controlled, to reduce exposure.
• Rapid and ultrarapid metabolizers clear PPIs quickly. About 3 in 10 people of European ancestry fall into these groups. They are more likely to have symptoms that don't respond and may need a higher dose.

Learn more about CYP2C19 and PPI dosing in Your genetics determines the effectiveness of Tecta for you.

How can you lower your risk of side effects?

• Use the lowest dose that works. The American Gastroenterological Association advises reviewing long-term PPI doses regularly.
• Ask whether you still need a PPI. A Canadian guideline recommends reducing the dose, stopping or using a PPI only when needed for adults whose heartburn or mild to moderate GERD has been controlled for at least 4 weeks. This does not apply to people with Barrett's esophagus, severe esophagitis or a history of bleeding ulcers, who usually need long-term treatment.
• Don't stop suddenly. Talk to your prescriber about tapering to avoid rebound acid.
• Know your genes. A CYP2C19 result can help your prescriber choose the right PPI and dose.

Is it safe to take Tecta long term?

For people who need it, such as those with Barrett's esophagus, severe esophagitis or a high risk of ulcers from anti-inflammatory painkillers, the benefits of long-term PPI treatment usually outweigh the risks. Long-standing, untreated GERD can lead to Barrett's esophagus, which increases the risk of esophageal cancer. If you take a PPI long term, review your need for it and your dose with your prescriber at least once a year.

Can a pharmacogenetic test help?

Pillcheck reports CYP2C19 along with 23 other genes and 355 medications, which account for over 70% of dispensed prescriptions. A Pillcheck pharmacist reviews your results and all your medications and recommends options and doses to discuss with your prescriber. Many insurance plans and health spending accounts cover Pillcheck; visit our insurance information page for details.

Summary

• Tecta and other PPIs are safe and effective for most people.
• Common side effects include headache, nausea, diarrhea and stomach pain.
• In a large 3-year trial, pantoprazole did not increase the risk of pneumonia, fractures, kidney disease or dementia, apart from a small increase in gut infections.
• Long-term use can lower magnesium and vitamin B12 levels, and stopping suddenly can cause rebound acid.
• CYP2C19 genes affect PPI levels; poor and intermediate metabolizers on long-term treatment may need a lower dose.

Frequently asked questions

What are the most common side effects of Tecta?

Headache, nausea, diarrhea, constipation, stomach pain and gas. They are usually mild.

Does Tecta cause bone fractures or kidney disease?

Observational studies have suggested a link, but a large randomized trial of pantoprazole for 3 years found no increase in fractures or kidney disease.

Can PPIs cause low magnesium or vitamin B12?

Yes, with long-term use. Your health care provider may check your levels if you have symptoms or other risk factors.

How do I stop taking Tecta?

Talk to your prescriber first. Lowering the dose gradually or taking it only when needed can help prevent rebound heartburn.

Can my genes increase my risk of PPI side effects?

Yes. CYP2C19 poor and intermediate metabolizers have higher PPI levels, and guidelines suggest a lower long-term dose for them.

References

Ha H, Lee HW, Park JE, Ye BS, Yu YM, Ah YM. Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta-Analysis. Clin Pharmacol Ther. 2026.

Moayyedi P, Eikelboom JW, Bosch J, et al. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. Gastroenterology. 2019;157(3):682-691.

Freedberg DE, Kim LS, Yang YX. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017;152(4):706-715.

Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline. Can Fam Physician. 2017;63(5):354-364.

Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009;137(1):80-87.

Lima JJ, Thomas CD, Barbarino J, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. Clin Pharmacol Ther. 2021;109(6):1417-1423.